Zucara Therapeutics raised $20M in a Series B funding led by Sanofi and The Perceptive Xontogeny Venture Fund to support the Phase 2a trial of ZT-01 for Type 1 diabetes.
Amount Raised
$20 Million
Round Type
Series B
TorontoBiotechnologyHealth CareTherapeuticsInvestors
Description
Zucara Therapeutics, based in Toronto, Canada, secured $20M in Series B financing to advance their ongoing clinical trials for ZT-01. The funding will primarily support research for a once-weekly version of the therapeutic designed for diabetes management.
Quick answer
Zucara Therapeutics raised $20 Million in a Series B round, dated November 12, 2024. Investors: Sanofi and The Perceptive Xontogeny Venture Fund. Zucara Therapeutics is based in Toronto, Ontario, Canada.
- How much did Zucara Therapeutics raise?
- Zucara Therapeutics raised $20 Million in a Series B round on November 12, 2024.
- Who invested in Zucara Therapeutics?
- Sanofi and The Perceptive Xontogeny Venture Fund are named as investors in this round.
- What does Zucara Therapeutics do?
- Zucara Therapeutics, a CDRD and MaRS Innovation portfolio company, is developing the first drug therapy to prevent hypoglycemia in people with diabetes.
- Where is Zucara Therapeutics based and how big is it?
- Zucara Therapeutics is based in Toronto, Ontario, Canada. Fundz records about 10 employees.
- Who are the decision-makers at Zucara Therapeutics?
- Fundz holds 1 contact at Zucara Therapeutics, including the Co Founder & Chief Scientific Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Zucara Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- AusperBio raised $73M (Series B) on December 27, 2024.
- Phio Pharmaceuticals raised $30K (Seed) on December 24, 2024.
- GEMMABio raised $34M (Series A) on December 23, 2024.
- Lipella Pharmaceuticals raised $2.6M (Seed) on December 23, 2024.
- Phio Pharmaceuticals raised $55K (Seed) on December 20, 2024.
- Borealis Biosciences raised $30M (Series A) on December 19, 2024.
Who to call at Zucara Therapeutics, and when
A new round usually means Zucara Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Zucara Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Zucara Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Zucara Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Zucara Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansZucara Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.